Literature DB >> 12869025

Immune complex-FcgammaR interaction modulates monocyte/macrophage molecules involved in inflammation and immune response.

P Barrionuevo1, M Beigier-Bompadre, G C Fernandez, S Gomez, M F Alves-Rosa, M S Palermo, M A Isturiz.   

Abstract

The interaction between receptors for the Fc portion of IgG (FcgammaRs) from monocytes/macrophages and immune complexes (IC) triggers regulatory and effector functions. Recently, we have demonstrated that IC exert a drastic inhibition of basal and IFN-gamma-induced expression of MHC class II on human monocytes. Taking into account that the regulation of MHC class II molecules is a crucial event in the immune response, in this report we extend our previous studies analysing the effect of STAT-1 phosphorylation in the down-regulatory process, the fate of the intracellular pool of MHC class II molecules and the effect of complement on MHC class II down-regulation induced by IC. We also studied the effect of IC on the expression of MHC class II (I-A(d)) in macrophages using a mouse model of chronic inflammation. We demonstrate that IC induce a depletion not only on surface expressed but also on intracellular MHC class II content and that IC-induced down-regulation of MHC class II is not mediated by the inhibition of STAT-1 phosphorylation. On the other hand, the effect of IC is not specific for the down-regulation of MHC class II, for it could be restricted to other molecules involved in inflammatory processes. Our experiments also show that the activation of the complement system could be a crucial step on the regulation of the effect of IC on MHC class II expression. In agreement with our in vitro experiments using human monocytes, IC treatment reduces the expression of MHC class II in a mouse model of chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869025      PMCID: PMC1808765          DOI: 10.1046/j.1365-2249.2003.02208.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  A new complement function: solubilization of antigen-antibody aggregates.

Authors:  G W Miller; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

Review 3.  Mechanism of solubilization of immune aggregates by complement. Implications for immunopathology.

Authors:  M Takahashi; J Czop; A Ferreira; V Nussenzweig
Journal:  Transplant Rev       Date:  1976

Review 4.  Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.

Authors:  M Takahashi; S Takahashi; S Hirose
Journal:  Prog Allergy       Date:  1980

5.  Immune complexes (IC) down-regulate the basal and interferon-gamma-induced expression of MHC class II on human monocytes.

Authors:  P Barrionuevo; M Beigier-Bompadre; S De La Barrera; M F Alves-Rosa; G Fernandez; M S Palermo; M A Isturiz
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

6.  Antigen-antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages.

Authors:  R J Bonney; P Naruns; P Davies; J L Humes
Journal:  Prostaglandins       Date:  1979-10

7.  Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.

Authors:  J A Schifferli; P Woo; D K Peters
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

8.  Inhibition of immune precipitation by complement.

Authors:  J A Schifferli; S R Bartolotti; D K Peters
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

9.  Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes.

Authors:  M Takahashi; B F Tack; V Nussenzweig
Journal:  J Exp Med       Date:  1977-01-01       Impact factor: 14.307

10.  Studies on the mechanism of solubilization of immune precipitates by serum.

Authors:  J Czop; V Nussenzweig
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

View more
  6 in total

1.  The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production.

Authors:  Paul Gallo; Ricardo Gonçalves; David M Mosser
Journal:  Immunol Lett       Date:  2010-07-27       Impact factor: 3.685

2.  Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury.

Authors:  Julie Belliere; Audrey Casemayou; Laure Ducasse; Alexia Zakaroff-Girard; Frédéric Martins; Jason S Iacovoni; Céline Guilbeau-Frugier; Bénédicte Buffin-Meyer; Bernard Pipy; Dominique Chauveau; Joost P Schanstra; Jean-Loup Bascands
Journal:  J Am Soc Nephrol       Date:  2014-09-30       Impact factor: 10.121

3.  Monocyte polarization: the relationship of genome-wide changes in H4 acetylation with polarization.

Authors:  Z Zhang; L Song; K Maurer; A Bagashev; K E Sullivan
Journal:  Genes Immun       Date:  2011-03-31       Impact factor: 2.676

4.  Extraordinarily potent proinflammatory properties of lactoferrin-containing immunocomplexes against human monocytes and macrophages.

Authors:  Lulu Hu; Xiaomin Hu; Kai Long; Chenhui Gao; Hong-Liang Dong; Qiao Zhong; Xiao-Ming Gao; Fang-Yuan Gong
Journal:  Sci Rep       Date:  2017-06-26       Impact factor: 4.379

5.  Nanobody Nb6 fused with porcine IgG Fc as the delivering tag to inhibit porcine reproductive and respiratory syndrome virus replication in porcine alveolar macrophages.

Authors:  Lu Zhang; Lizhen Wang; Shuaishuai Cao; Huanhuan Lv; Jingjing Huang; Guixi Zhang; Kaissar Tabynov; Qin Zhao; En-Min Zhou
Journal:  Vet Res       Date:  2021-02-17       Impact factor: 3.683

6.  Aminopeptidase N (CD13) functionally interacts with FcgammaRs in human monocytes.

Authors:  Paola Mina-Osorio; Enrique Ortega
Journal:  J Leukoc Biol       Date:  2005-03-09       Impact factor: 4.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.